You are here
- Home
- Last 30 days trials
A Randomized, 2-Part, Crossover, Single Center Study to Evaluate Effect of Quinidine on the Pharmacokinetics of NKTR-118 and the Concomitant Effect of Quinidine and NKTR-118 on Morphine-induced Miosis.
- Disease
- pharmacokinetics
- Drug Name
- AstraZeneca Neuroscience Development Drugs
- Generic Name
- NKTR-118
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- NKTR-118
- Study Id
- D3820C00011
- ClinicalTrials.gov ID
- NCT01533155
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
